Suppr超能文献

衰老大脑适应性研究 II(FABS II):一项随机对照临床试验的方案,旨在评估身体活动对阿尔茨海默病患者认知功能的影响。

The fitness for the Ageing Brain Study II (FABS II): protocol for a randomized controlled clinical trial evaluating the effect of physical activity on cognitive function in patients with Alzheimer's disease.

机构信息

National Ageing Research Institute, Melbourne, Australia.

出版信息

Trials. 2010 Dec 10;11:120. doi: 10.1186/1745-6215-11-120.

Abstract

BACKGROUND

Observational studies have documented a potential protective effect of physical exercise in older adults who are at risk for developing Alzheimer's disease. The Fitness for the Ageing Brain II (FABS II) study is a multicentre randomized controlled clinical trial (RCT) aiming to determine whether physical activity reduces the rate of cognitive decline among individuals with Alzheimer's disease. This paper describes the background, objectives of the study, and an overview of the protocol including design, organization and data collection methods.

METHODS/DESIGN: The study will recruit 230 community-dwelling participants diagnosed with Alzheimer's disease. Participants will be randomly allocated to two treatment groups: usual care group or 24-week home-based program consisting of 150 minutes per week of tailored moderate physical activity. The primary outcome measure of the study is cognitive decline as measured by the change from baseline in the total score on the Alzheimer's disease Assessment Scale-Cognitive section. Secondary outcomes of interest include behavioral and psychological symptoms, quality of life, functional level, carer burden and physical function (strength, balance, endurance, physical activity). Primary endpoints will be measured at six and twelve months following the baseline assessment.

DISCUSSION

This RCT will contribute evidence regarding the potential benefits of a systematic program of physical activity as an affordable and safe intervention for people with Alzheimer's disease. Further, if successful, physical activity in combination with usual care has the potential to alleviate the symptoms of Alzheimer's disease and improve its management and the quality of life of patients and their carers.

TRIAL REGISTRATION

Australia New Zealand Clinical Trials Registry ACTRN12609000755235.

摘要

背景

观察性研究记录了体力活动对有患阿尔茨海默病风险的老年人的潜在保护作用。衰老大脑适应能力 II 期研究(FABS II)是一项多中心随机对照临床试验(RCT),旨在确定体力活动是否能降低阿尔茨海默病患者的认知能力下降速度。本文介绍了该研究的背景、目的和方案概述,包括设计、组织和数据收集方法。

方法/设计:该研究将招募 230 名被诊断患有阿尔茨海默病的社区居民参与者。参与者将被随机分配到两个治疗组:常规护理组或为期 24 周的家庭基础方案,包括每周 150 分钟的量身定制的适度体力活动。研究的主要结果测量是认知能力下降,通过阿尔茨海默病评估量表认知部分的基线变化来衡量。感兴趣的次要结果包括行为和心理症状、生活质量、功能水平、照顾者负担和身体功能(力量、平衡、耐力、体力活动)。主要终点将在基线评估后 6 个月和 12 个月进行测量。

讨论

这项 RCT 将提供关于系统体力活动计划作为一种负担得起且安全的阿尔茨海默病干预措施的潜在益处的证据。此外,如果成功,体力活动与常规护理相结合有可能减轻阿尔茨海默病的症状,并改善其管理以及患者及其照顾者的生活质量。

试验注册

澳大利亚新西兰临床试验注册中心 ACTRN12609000755235。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add2/3016362/309576d93c1b/1745-6215-11-120-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验